Diederik Bulters Selected Research

4-amino-tetrahydrobiopterin

12/2020	Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study.
1/2020	Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study.
10/2014	Nitric oxide synthase inhibition with the antipterin VAS203 improves outcome in moderate and severe traumatic brain injury: a placebo-controlled randomized Phase IIa trial (NOSTRA).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diederik Bulters Research Topics

Disease

5	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2020 - 10/2014
4	Aneurysm (Aneurysms) 07/2022 - 01/2018
3	Intracranial Aneurysm (Cerebral Aneurysm) 03/2022 - 06/2018
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2022 - 05/2017
2	Rupture 06/2018 - 01/2018
1	Hemorrhage 01/2022
1	Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula) 01/2022
1	Hematoma 12/2020
1	Chronic Subdural Hematoma 12/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Cysts 01/2020
1	Edema (Dropsy) 01/2020
1	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 01/2019
1	Infections 01/2019
1	Seizures (Absence Seizure) 01/2019
1	Auditory Perceptual Disorders (Auditory Processing Disorder) 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 12/2018
1	Neoplasms (Cancer) 01/2018
1	Hypercholesterolemia 01/2018
1	Residual Neoplasm 01/2018
1	Intracranial Vasospasm 05/2017
1	Inflammation (Inflammations) 01/2017
1	Dementia (Dementias) 01/2016
1	Acute Kidney Injury (Acute Renal Failure) 10/2014

Drug/Important Bio-Agent (IBA)

3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2022 - 01/2018
3	4-amino-tetrahydrobiopterinIBA 12/2020 - 10/2014
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2016
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 01/2022
1	C-Reactive ProteinIBA 10/2021
1	AngiopoietinsIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	IronIBA 01/2019
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2019
1	SteroidsIBA 12/2018
1	Matrix Metalloproteinases (MMPs)IBA 06/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2017
1	Reducing AgentsIBA 05/2017
1	CholesterolIBA 05/2017
1	Blood Proteins (Serum Proteins)IBA 01/2017
1	HaptoglobinsIBA 01/2017
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2014

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020
1	Conservative Treatment 01/2022
1	Craniotomy 01/2020
1	Duration of Therapy 01/2019
1	Decompressive Craniectomy 01/2019
1	Catheters 01/2019
1	Cerebrospinal Fluid Shunts 12/2018
1	Contraindications 12/2018
1	Operative Time 01/2018